Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cedo Miljevic, Ana Munjiza-Jovanovic & Teodora Jovanovic. (2023) Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia. Neuropsychiatric Disease and Treatment 19, pages 579-586.
Read now
Read now
João V. Nani, Priscila G. C Almeida, Cristiano Noto, Rodrigo A. Bressan, Elisa Brietzke & Mirian A. F Hayashi. (2022) Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia. Nordic Journal of Psychiatry 76:7, pages 559-564.
Read now
Read now
Articles from other publishers (55)
V. V. Stanovaya, Z. T. Guseynova, M. V. Ivanov & E. V. Bigday. (2023) The phenomenon of therapeutic resistance in the treatment of schizophrenia: the possibilities of modern diagnostics and methods of anti-resistant effects. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 57:4, pages 120-130.
Crossref
Crossref
Jason Smucny, Cameron S. Carter & Richard J. Maddock. (2023) Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant vs. Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-Analysis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Crossref
Crossref
Honey Kim, Seon-Hwa Baek, Ju-Wan Kim, Seunghyong Ryu, Ju-Yeon Lee, Jae-Min Kim, Young-Chul Chung & Sung-Wan Kim. (2023) Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia. Schizophrenia 9:1.
Crossref
Crossref
Paris Alexandros Lalousis, Lianne Schmaal, Stephen J. Wood, Renate L.E.P Reniers, Vanessa L. Cropley, Andrew Watson, Christos Pantelis, John Suckling, Nicholas M. Barnes, Carmine Pariante, Peter B. Jones, Eileen Joyce, Thomas R.E. Barnes, Stephen M. Lawrie, Nusrat Husain, Paola Dazzan, Bill Deakin, Cynthia Shannon Weickert & Rachel Upthegrove. (2023) Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity. Brain, Behavior, and Immunity 113, pages 166-175.
Crossref
Crossref
Sarah E. Herniman, Stephen J. Wood, Golam Khandaker, Paola Dazzan, Carmine M. Pariante, Nicholas M. Barnes, Carl R. Krynicki, Naghmeh Nikkheslat, Rachel C. Vincent, Alex Roberts, Annalisa Giordano, Andrew Watson, John Suckling, Thomas R. E. Barnes, Nusrat Husain, Peter B. Jones, Eileen Joyce, Stephen M. Lawrie, Shôn Lewis, Bill Deakin & Rachel Upthegrove. (2023) Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial. Translational Psychiatry 13:1.
Crossref
Crossref
Xue Xin Goh, Pek Yee Tang & Shiau Foon Tee. (2023) Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses. Journal of Psychiatric Research 165, pages 180-190.
Crossref
Crossref
Jakleen J. Lee, Enrica Piras, Sabrina Tamburini, Kevin Bu, David S. Wallach, Brooke Remsen, Adam Cantor, Jennifer Kong, Deborah Goetz, Kevin W. Hoffman, Mharisi Bonner, Peter Joe, Bridget R. Mueller, Jessica Robinson-Papp, Eyal Lotan, Oded Gonen, Dolores Malaspina & Jose C. Clemente. (2023) Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot study. Psychiatry Research 326, pages 115279.
Crossref
Crossref
Paulo Levi Bezerra Martins, Ian Araújo Moura, Gabrielle Mendes, Vitória Cristina Almeida Flexa Ribeiro, André Arnaud, Clarissa S. Gama, Michael Maes, Danielle S. Macedo & Joel Porfirio Pinto. (2023) Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis. European Neuropsychopharmacology 73, pages 82-95.
Crossref
Crossref
Wenjin Chen, Mengzhuang Gou, Leilei Wang, Na Li, Wei Li, Jinghui Tong, Yanfang Zhou, Ting Xie, Ting Yu, Wei Feng, Yanli Li, Song Chen, Baopeng Tian, Shuping Tan, Zhiren Wang, Shujuan Pan, Xingguang Luo, Ping Zhang, Junchao Huang, Li Tian, Chiang-Shan R. Li & Yunlong Tan. (2023) Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia. European Neuropsychopharmacology 72, pages 18-29.
Crossref
Crossref
Haidong Yang, Jing Zhang, Man Yang, Li Xu, Wanming Chen, Yujun Sun & Xiaobin Zhang. (2023) Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients. Asian Journal of Psychiatry 79, pages 103400.
Crossref
Crossref
Hussein Kadhem Al-Hakeim, Mazin Fadhil Altufaili, Abbas F. Almulla, Shatha Rouf Moustafa & Michael Maes. (2022) Increased Lipid Peroxidation and Lowered Antioxidant Defenses Predict Methamphetamine Induced Psychosis. Cells 11:22, pages 3694.
Crossref
Crossref
Paris Alexandros Lalousis, Lianne Schmaal, Stephen J. Wood, Renate L.E.P. Reniers, Nicholas M. Barnes, Katharine Chisholm, Sian Lowri Griffiths, Alexandra Stainton, Junhao Wen, Gyujoon Hwang, Christos Davatzikos, Julian Wenzel, Lana Kambeitz-Ilankovic, Christina Andreou, Carolina Bonivento, Udo Dannlowski, Adele Ferro, Theresa Lichtenstein, Anita Riecher-Rössler, Georg Romer, Marlene Rosen, Alessandro Bertolino, Stefan Borgwardt, Paolo Brambilla, Joseph Kambeitz, Rebekka Lencer, Christos Pantelis, Stephan Ruhrmann, Raimo K.R. Salokangas, Frauke Schultze-Lutter, André Schmidt, Eva Meisenzahl, Nikolaos Koutsouleris, Dominic Dwyer & Rachel Upthegrove. (2022) Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes. Biological Psychiatry 92:7, pages 552-562.
Crossref
Crossref
Abbas F. Almulla, Asara Vasupanrajit, Chavit Tunvirachaisakul, Hussein K. Al-Hakeim, Marco Solmi, Robert Verkerk & Michael Maes. (2022) The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Molecular Psychiatry 27:9, pages 3679-3691.
Crossref
Crossref
Junyang Wang, Shiwu Li, Xiaoyan Li, Jiewei Liu, Jinfeng Yang, Yifan Li, Wenqiang Li, Yongfeng Yang, Jiao Li, Rui Chen, Kaiqin Li, Di Huang, Yixing Liu, Luxian Lv, Ming Li, Xiao Xiao & Xiong Jian Luo. (2022)
Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating
NMRAL1
. Brain 145:7, pages 2569-2585.
Crossref
Crossref
Narasimha M. Beeraka, Marco F. Avila-Rodriguez & Gjumrakch Aliev. (2022) Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia. Molecular Neurobiology 59:4, pages 2472-2496.
Crossref
Crossref
Damodharan Dinakaran, Vanteemar S. SreerajGanesan Venkatasubramanian. (2021) Role of Curcumin in the Management of Schizophrenia: A Narrative Review. Indian Journal of Psychological Medicine 44:2, pages 107-113.
Crossref
Crossref
Caleb Labonté, Naista Zhand, Angela Park & Philip D. Harvey. (2022) Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation. Psychiatry Research 308, pages 114382.
Crossref
Crossref
Mandakh Bekhbat, Michael T. Treadway & Jennifer C. Felger. 2022. Anhedonia: Preclinical, Translational, and Clinical Integration. Anhedonia: Preclinical, Translational, and Clinical Integration
397
419
.
V. L. Ushakov, I. K. Malashenkova, G. P. Kostyuk, N. V. Zakharova, S. A. Krynskiy, S. I. Kartashov, D. P. Ogurtsov, L. V. Bravve, M. A. Kaydan, N. A. Hailov, E. I. Chekulaeva & N. A. Didkovsky. (2021) The Relationship between Inflammation, Cognitive Impairments, and Neuroimaging Data in Schizophrenia. Neuroscience and Behavioral Physiology 51:7, pages 873-881.
Crossref
Crossref
Hussein Kadhem Al-Hakeim, Rana Fadhil Mousa, Arafat Hussein Al-Dujaili & Michael Maes. (2021) In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy. Metabolic Brain Disease 36:5, pages 939-955.
Crossref
Crossref
Daniela Enache, Naghmeh Nikkheslat, Dina Fathalla, B. Paul Morgan, Shôn Lewis, Richard Drake, Bill Deakin, James Walters, Stephen M. Lawrie, Alice Egerton, James H. MacCabe & Valeria Mondelli. (2021) Peripheral immune markers and antipsychotic non-response in psychosis. Schizophrenia Research 230, pages 1-8.
Crossref
Crossref
Irina K. Malashenkova, Sergey A. Krynskiy, Daniil P. Ogurtsov, Nikita A. Hailov, Natalia V. Zakharova, Lidia V. Bravve, Maria A. Kaydan, Ekaterina I. Chekulaeva, Denis S. Andreyuk, Vadim L. Ushakov, Nikolay A. Didkovsky & Georgy P. Kostyuk. (2021) Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia. Consortium Psychiatricum 2:1, pages 19-31.
Crossref
Crossref
Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al-Hakeim & Michael Maes. (2021) High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments. Schizophrenia Bulletin 47:2, pages 530-541.
Crossref
Crossref
Shih-Jen Tsai. (2021) Role of interleukin 8 in depression and other psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110173.
Crossref
Crossref
Marion Leboyer, Ophélia Godin, Emilie Terro, Wahid Boukouaci, Ching-lieng Lu, Myrtille Andre, Bruno Aouizerate, Fabrice Berna, Caroline Barau, Delphine Capdevielle, Julie Clauss-Kobayashi, Isabelle Chereau, Thierry D′Amato, Caroline Dubertret, Julien Dubreucq, Guillaume Fond, Hakim Laouamri, Sylvain Leignier, Christophe Lancon, Pierre-Michel Llorca, Jasmina Mallet, Philippe Le Corvoisier, David Misdrahi, Christine Passerieux, Romain Rey, Baptiste Pignon, Mathieu Urbach, Andrei Szoke, Franck Schürhoff, Ryad Tamouza, F Berna, E Haffen, M Leboyer, P M Llorca, F Schürhoff, V Barteau, S Bensalem, O Godin, H Laouamri, K Souryis, M Leboyer, I Offerlin-Meyer, B Pignon, F Schürhoff, A Szöke, B Aouizerate, A Deloge, D Misdrahi, E Vilà, O Blanc, I Chéreau, H Denizot, R M Honciuc, D Lacelle, P M Llorca, S Pires, C Dubertret, J Mallet, C Portalier, J Dubreucq, C Fluttaz, F Gabayet, C Roman, G Chesnoy-Servanin, T D′Amato, J M Dorey, R Rey, A Vehier, C Lançon, C Faget, E Metairie, P Peri, F Vaillant, F Berna, P Vidailhet, A Zinetti-Bertschy, D Capdevielle, H Yazbek, S Esselin, M Jarroir, C Passerieux & M Urbach. (2021) Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study. Schizophrenia Bulletin Open 2:1.
Crossref
Crossref
Mahdiyeh Moudi, Saman Sargazi, Milad Heidari Nia, Ramin Saravani, Milad Shirvaliloo & Mansoor Shakiba. (2020) Polymorphism in the 3′-UTR of LIF but Not in the ATF6B Gene Associates with Schizophrenia Susceptibility: a Case-Control Study and In Silico Analyses. Journal of Molecular Neuroscience 70:12, pages 2093-2101.
Crossref
Crossref
Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson & Oliver D. Howes. (2020) The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research. FOCUS 18:4, pages 456-465.
Crossref
Crossref
Mariya Ivanovska, Zakee Abdi, Marianna Murdjeva, Danielle Macedo, Annabel Maes & Michael Maes. (2020) CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders. Pharmaceuticals 13:9, pages 230.
Crossref
Crossref
Shatha Rouf Moustafa, Khalid F. Al-Rawi, Drozdstoi Stoyanov, Arafat Hussein Al-Dujaili, Thitiporn Supasitthumrong, Hussein Kadhem Al-Hakeim & Michael Maes. (2020) The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6. Diagnostics 10:9, pages 633.
Crossref
Crossref
Maren Caroline Frogner Werner, Katrine Verena Wirgenes, Marit Haram, Francesco Bettella, Synve Hoffart Lunding, Linn Rødevand, Gabriela Hjell, Ingrid Agartz, Srdjan Djurovic, Ingrid Melle, Ole A. Andreassen & Nils Eiel Steen. (2020) Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders. Schizophrenia Research 218, pages 55-62.
Crossref
Crossref
Hussein Kadhem Al-Hakeim, Abbas F. Almulla & Michael Maes. (2020) The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study. Neurotoxicity Research 37:3, pages 753-771.
Crossref
Crossref
David R. Goldsmith & Mark Hyman Rapaport. (2020) Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits. Frontiers in Psychiatry 11.
Crossref
Crossref
Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson & Oliver D. Howes. (2020) The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. npj Schizophrenia 6:1.
Crossref
Crossref
V.L. Ushakov, I.K. Malashenkova, G.P. Kostyuk, N.V. Zakharova, S.A. Krynskiy, S.I. Kartashov, D.P. Ogurtsov, L.V. Bravve, M.A. Kaydan, N.A. Hailov, E.I. Chekulaeva & N.A. Didkovsky. (2020) The relationship between inflammation, cognitive disorders and neuroimaging data in schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:11, pages 70.
Crossref
Crossref
Laís Bhering Martins, Silvia Fernandes Mauricio, Adaliene Versiani Matos Ferreira & Antônio Lúcio Teixeira. 2020. Obesity and Diabetes. Obesity and Diabetes
415
426
.
Sara Momtazmanesh, Ameneh Zare-Shahabadi & Nima Rezaei. (2019) Cytokine Alterations in Schizophrenia: An Updated Review. Frontiers in Psychiatry 10.
Crossref
Crossref
Fernanda Endler Valiati, Gabriel Henrique Hizo, Jairo Vinícius Pinto & Márcia Kauer-Sant`Anna. (2019) The Possible Role of Telomere Length and Chemokines in the Aging Process: A Transdiagnostic Review in Psychiatry. Current Psychiatry Research and Reviews 15:3, pages 171-192.
Crossref
Crossref
Estefania Gastaldello Moreira, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello & Michael Maes. (2019) Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?. Current Neuropharmacology 17:11, pages 1004-1020.
Crossref
Crossref
Veronica L Hood, Ralph Berger, Robert Freedman & Amanda J Law. (2019) Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines. Human Molecular Genetics 28:19, pages 3188-3198.
Crossref
Crossref
Laís Bhering Martins, Nayara Mussi Monteze, Chadi Calarge, Adaliene Versiani Matos Ferreira & Antônio Lúcio Teixeira. (2019) Pathways linking obesity to neuropsychiatric disorders. Nutrition 66, pages 16-21.
Crossref
Crossref
Mikuni Motoyama, Hisashi Yamada, Masamichi Motonishi & Hisato Matsunaga. (2019) Elevated anti-gliadin IgG antibodies are related to treatment resistance in schizophrenia. Comprehensive Psychiatry 93, pages 1-6.
Crossref
Crossref
Buranee Kanchanatawan, Sira Sriswasdi & Michael Maes. (2018) Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Metabolic Brain Disease 34:1, pages 267-282.
Crossref
Crossref
Pablo Gómez-Rubio & Isabel Trapero. (2019) The Effects of Exercise on IL-6 Levels and Cognitive Performance in Patients with Schizophrenia. Diseases 7:1, pages 11.
Crossref
Crossref
Leticia González-Blanco, María P. García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2019) Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?. Revista de Psiquiatría y Salud Mental (English Edition) 12:1, pages 9-16.
Crossref
Crossref
Leticia González-Blanco, María P. García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2019) ¿Pueden ser la interleucina-2 y la interleucina-1β biomarcadores específicos de la sintomatología negativa en la esquizofrenia?. Revista de Psiquiatría y Salud Mental 12:1, pages 9-16.
Crossref
Crossref
Leticia González-Blanco, María Paz García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2018) Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia. Revista de Psiquiatría y Salud Mental (English Edition) 11:3, pages 130-140.
Crossref
Crossref
Leticia González-Blanco, María Paz García-Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar A. Sáiz, Susana Rodríguez-González, Ana Coto-Montes & Julio Bobes. (2018) Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia. Revista de Psiquiatría y Salud Mental 11:3, pages 130-140.
Crossref
Crossref
Antonio L. Teixeira, Clarissa S. Gama, Natalia P. Rocha & Mauro M. Teixeira. (2018) Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders. Frontiers in Psychiatry 9.
Crossref
Crossref
Tohru Ohnuma, Shohei Nishimon, Mayu Takeda, Takahiro Sannohe, Narimasa Katsuta & Heii Arai. (2018) Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia. Frontiers in Psychiatry 9.
Crossref
Crossref
I. K. Malashenkova, S. A. Krynskiy, D. P. Ogurtsov, M. V. Mamoshina, N. V. Zakharova, V. L. Ushakov, B. M. Velichkovsky & N. A. Didkovsky. (2018) A role of the immune system in the pathogenesis of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:12, pages 72.
Crossref
Crossref
Joana Prata, Susana G. Santos, Maria Inês Almeida, Rui Coelho & Mário A. Barbosa. (2017) Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations. Journal of Neuroinflammation 14:1.
Crossref
Crossref
Monojit Debnath & Michael Berk. (2016) Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia. Molecular Neurobiology 54:10, pages 8170-8178.
Crossref
Crossref
Karine Maria Boll, Cristiano Noto, Kamila Landucci Bonifácio, Chiara Cristina Bortolasci, Ary Gadelha, Rodrigo Affonseca Bressan, Décio Sabbatini Barbosa, Michael Maes & Estefania Gastaldello Moreira. (2017) Oxidative and nitrosative stress biomarkers in chronic schizophrenia. Psychiatry Research 253, pages 43-48.
Crossref
Crossref
Krzysztof Krysta, Marek Krzystanek, Agnieszka Bratek & Irena Krupka-Matuszczyk. (2015) Sleep and inflammatory markers in different psychiatric disorders. Journal of Neural Transmission 124:S1, pages 179-186.
Crossref
Crossref
Lindsay Joy Spielman, Jonathan Peter Little & Andis Klegeris. (2016) Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Research Bulletin 125, pages 19-29.
Crossref
Crossref